Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
(1)
About
Emcure Pharmaceuticals Ltd.
NSE: EMCURE
|
BSE: 544210
|
ISIN: INE168P01015
|
Industry: Pharmaceuticals
Margin Growth
|
Strong Performer, Getting Expensive
1643.0000
-21.80
(
-1.31
%)
NSE
May 08, 2026
15:57 PM
New 52W High in past week
Volume:
263.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Emcure Pharmaceuticals Ltd.
03 Jul 2024
Margin Growth
1643.00
-1.31%
EMCURE PHARMACEUTICAL LIMITED
IPO Subscribe:
Emcure Pharmaceuticals Ltd.
by
Hem Securities
Hem Securities
Emcure Pharma has gained
61.70%
in the last 1 Year
More from Emcure Pharmaceuticals Ltd.
Recommended
Market closes lower amid rising tensions in the Strait of Hormuz
Trendlyne Marketwatch |
08 May 2026, 04:09PM
What drove multibaggers in FY26: Order books, commodity cycles and turnaround plays
The Baseline |
07 May 2026, 01:14PM
Five stocks to buy from analysts this week - May 6, 2026
The Baseline |
06 May 2026